Cargando…
CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease
The oxidative degradation of lipids has been shown to be implicated in the progression of several neurodegenerative diseases and modulating lipid peroxidation may be efficacious for treating Alzheimer’s disease (AD). This hypothesis is strengthened by recent findings suggesting that oxytosis/ferropt...
Autores principales: | Ates, Gamze, Goldberg, Joshua, Currais, Antonio, Maher, Pamela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394765/ https://www.ncbi.nlm.nih.gov/pubmed/32863221 http://dx.doi.org/10.1016/j.redox.2020.101648 |
Ejemplares similares
-
Attenuation of Age-Related Hearing Impairment in Senescence-Accelerated Mouse Prone 8 (SAMP8) Mice Treated with Fatty Acid Synthase Inhibitor CMS121
por: Pham, Tammy B., et al.
Publicado: (2023) -
The Geroprotective Drug Candidate CMS121 Alleviates Diabetes, Liver Inflammation, and Renal Damage in db/db Leptin Receptor Deficient Mice
por: Zahid, Saadia, et al.
Publicado: (2023) -
Targeting of intracellular Ca(2+) stores as a therapeutic strategy against age-related neurotoxicities
por: Goldberg, Joshua, et al.
Publicado: (2020) -
Elevating acetyl-CoA levels reduces aspects of brain aging
por: Currais, Antonio, et al.
Publicado: (2019) -
Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer’s disease transgenic mice
por: Currais, Antonio, et al.
Publicado: (2014)